Basal insulin and cardiovascular and other outcomes in dysglycemia

Research output: Contribution to journalJournal articleResearchpeer-review

  • Hertzel C Gerstein
  • Jackie Bosch
  • Gilles R Dagenais
  • Rafael Díaz
  • Hyejung Jung
  • Aldo P Maggioni
  • Janice Pogue
  • Jeffrey Probstfield
  • Ambady Ramachandran
  • Matthew C Riddle
  • Lars E Rydén
  • Salim Yusuf
  • ORIGIN Trial Investigators
  • Thure Krarup
  • Perrild, Hans
  • Torp-Pedersen, Christian Tobias
The provision of sufficient basal insulin to normalize fasting plasma glucose levels may reduce cardiovascular events, but such a possibility has not been formally tested.
Original languageEnglish
JournalNew England Journal of Medicine
Volume367
Issue number4
Pages (from-to)319-28
Number of pages10
ISSN0028-4793
DOIs
Publication statusPublished - 2012

ID: 48553971